Feline esophagitis History of food allergy IL-5 Diagnosis requires more than 15 eosinophils per high power field

Reading File
Finding Sources
Finding Sources
Searching PubMed

"eosinophilic esophagitis"[MeSH Terms] AND diagnosis

Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Loading Image
All the key information is in hand. Here is the complete answer:

Eosinophilic Esophagitis (EoE)

The four clues you listed - feline/ringed esophagus appearance, history of food allergy, IL-5 involvement, and the >15 eosinophils/HPF threshold - all point to Eosinophilic Esophagitis (EoE).

Definition

EoE is a chronic immune-mediated inflammatory disorder characterized by:
  • Esophageal dysfunction symptoms (dysphagia, food impaction in adults; feeding intolerance, GERD-like symptoms in children)
  • Histological eosinophilic infiltration of the esophageal epithelium
  • Yamada's Textbook of Gastroenterology, 7e
  • Robbins & Kumar Basic Pathology

Pathophysiology & Role of IL-5

EoE arises from an exaggerated Th2-mediated allergic immune response to food (and aeroallergens). Key cytokines involved:
CytokineRole
IL-5Major eosinophil growth factor, survival signal, and recruiter - drives eosinophilic infiltration of the esophagus
IL-13Induces esophageal epithelial barrier disruption and eotaxin-3 production
IL-33 / TSLPActivates T-regulatory and Th2 cells, initiating the inflammatory cascade
Eotaxin-3Chemokine that directly recruits eosinophils to the esophagus
IL-5 is so central that anti-IL-5 biologics (mepolizumab, reslizumab) have been studied as targeted therapies. - Yamada's Textbook of Gastroenterology, 7e, IL-4/IL-5/IL-13 section

Link to Food Allergy

  • Most patients have a personal or family history of atopic disease: allergic rhinitis, asthma, atopic dermatitis, or food allergy
  • Food antigen sensitization (particularly cow's milk, wheat, soy, eggs, nuts, seafood) is a major trigger
  • Sensitization often occurs via inflamed skin (the "outside-in" hypothesis), with re-exposure through ingestion driving esophageal inflammation
  • Removal of trigger foods via elemental or elimination diets results in histological remission in a significant proportion of patients
  • Sleisenger & Fordtran's GI and Liver Disease

Diagnostic Criteria

Diagnosis requires BOTH clinical and histological criteria:
  1. Symptoms of esophageal dysfunction
  2. Histology: ≥15 eosinophils per high-power field (eos/HPF) on esophageal biopsy (proximal AND distal biopsies)
  3. Exclusion of other causes of esophageal eosinophilia (GERD, parasitic infection, Crohn disease, drug-induced esophagitis, eosinophilic gastroenteritis)
  4. PPI-refractory course (helps distinguish from GERD-related eosinophilia)
"The eosinophil density required for the diagnosis of eosinophilic esophagitis is generally more than 15 eosinophils per high-power field on both proximal and distal esophageal biopsies." - Cummings Otolaryngology, Head & Neck Surgery
"The presence of at least 15 eosinophils per HPF is required for a diagnosis, and it is also a cut-off for histological remission (<15 eos/HPF)." - Yamada's Textbook of Gastroenterology, 7e
The eosinophilic infiltrate is often patchy, so multiple biopsies (at least 2-4 from proximal and distal esophagus) are recommended to avoid false negatives (~10% of biopsies nondiagnostic due to patchiness).

Endoscopic & Histologic Findings

Here are the classic findings side by side:
EoE histology and endoscopy: (A) Reflux esophagitis with scattered eosinophils; (B) EoE with numerous intraepithelial eosinophils and eosinophilic microabscesses; (C) Endoscopic view showing characteristic circumferential rings ("trachealization") of the proximal esophagus
Fig. 13.9 - Robbins & Kumar Basic Pathology: (A) Reflux esophagitis - scattered eosinophils; (B) EoE - numerous eosinophils with eosinophilic microabscesses (superficial clustering); (C) Endoscopy showing circumferential rings ("feline esophagus" / trachealization)
Endoscopic features:
  • Stacked concentric rings ("trachealization" or "feline esophagus") - fixed or transient
  • Longitudinal furrows
  • White exudates / eosinophilic microabscesses (can mimic candidiasis)
  • Mucosal friability ("crepe paper esophagus")
  • Strictures (proximal/mid esophagus - distinguishes from GERD which affects distal)
Histologic features:
  • ≥15 eos/HPF (superficial clustering is characteristic)
  • Eosinophilic microabscesses
  • Basal cell hyperplasia
  • Lamina propria fibrosis (subepithelial)

Key Differentiator from GERD

FeatureEoEGERD
LocationProximal/mid esophagusDistal esophagus
Eosinophils≥15/HPF, superficial clustersScattered, usually <10/HPF
PPI responseRefractoryResponsive
Atopic historyCommonNot typical
Rings/furrowsPresentAbsent

Treatment

  • Dietary elimination (6-food elimination diet or elemental formula)
  • Swallowed topical corticosteroids (fluticasone, budesonide) - first-line pharmacotherapy
  • Proton pump inhibitors - can induce remission in a subset (~30-40%, per recent meta-analysis, PMID 40089255)
  • Dupilumab (anti-IL-4Rα, blocks IL-4 and IL-13 signaling) - FDA-approved biologic; real-world effectiveness confirmed in systematic review (PMID 39998943)
  • Esophageal dilation for strictures/food impaction

Protein losing enteropathy Cerebriform appearance Menetrier ds Case study

Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
Loading Image
All the content needed is in hand. Here is the complete structured answer:

Ménétrier's Disease

The clues - protein-losing enteropathy + cerebriform (brain-like) appearance + gastric pathology - are the classic triad of Ménétrier's Disease, a rare hypertrophic gastropathy.

Definition

Ménétrier's disease (MD) is a rare disorder of the stomach characterized by:
  • Massive foveolar (mucous cell) hyperplasia of the body and fundus
  • Giant, tortuous gastric rugal folds with a cerebriform (brain-like) gross appearance
  • Protein-losing gastropathy with hypoalbuminemia
  • Achlorhydria / hypochlorhydria due to loss of parietal cell mass
  • Robbins, Cotran & Kumar Pathologic Basis of Disease
  • Harrison's Principles of Internal Medicine, 22e

Pathogenesis

The molecular driver is overexpression of TGF-α (Transforming Growth Factor-alpha):
TGF-α overexpression
        ↓
Overstimulation of EGFR (Epidermal Growth Factor Receptor) on gastric epithelial cells
        ↓
Massive proliferation of foveolar (surface mucous) cells
        ↓
Hyperplastic, elongated, tortuous, cystic glands → Giant rugal folds
        ↓
Loss of parietal cells → Hypochlorhydria/Achlorhydria
Loss of protein across leaky mucosa → Hypoalbuminemia → Edema
  • In children: most cases are triggered by CMV infection (CMV-induced EGFR activation) - typically self-limited
  • In adults: etiology often unknown; CMV and H. pylori have also been implicated
  • Yamada's Textbook of Gastroenterology, 7e
  • Harrison's Principles of Internal Medicine, 22e

Clinical Presentation

Demographics: Typically men, ages 40-60 years (male predominance)
Symptoms (insidious and progressive):
  • Epigastric pain, nausea, vomiting, anorexia
  • Peripheral edema - from hypoalbuminemia (albumin loss can approach 10 g/day)
  • Weight loss, diarrhea
  • Occult GI bleeding (from mucosal erosions)
20-100% of patients develop protein-losing gastropathy with hypoalbuminemia (depending on stage at presentation).

Classic Case Scenario

A 55-year-old man presents with progressive peripheral edema, epigastric discomfort, and weight loss over several months. Labs show hypoalbuminemia with a normal 24-hour urine protein. Upper endoscopy reveals massively enlarged, lobular, cerebriform gastric folds in the fundus and body with antral sparing. Biopsy shows massive foveolar hyperplasia with elongated, corkscrew-shaped, cystic glands and markedly reduced parietal and chief cells. Gastric acid secretion is absent.
Diagnosis: Ménétrier's Disease

Radiology

The barium meal/upper GI study is dramatic and characteristic:
Ménétrier Disease - Barium study showing massively enlarged, lobular, cerebriform folds in the gastric body with antral sparing. The folds remain pliable (distinguishing from malignancy)
Fig. 20.10 - Grainger & Allison's Diagnostic Radiology: Classic Ménétrier Disease with massively enlarged folds in the body, antrum spared. Note the convoluted, brain-like (cerebriform) appearance of the folds.
Key radiographic features:
  • Massively thickened, lobular, often bizarre gastric folds
  • Prominent in the proximal stomach and greater curvature
  • Antrum generally spared (though involved in up to 50% of cases)
  • Folds remain pliable (differentiates from carcinoma, where stomach is rigid/aperistaltic)
  • Increased fluid in small bowel may impair optimal barium coating

Histology

Ménétrier Disease histology - massively expanded foveolar (mucous cell) epithelium with elongated, tortuous, corkscrew-shaped glands and cystic dilation. Parietal and chief cells are markedly reduced
Fig. 51.16 - Yamada's Textbook of Gastroenterology: Massively expanded foveolar epithelium in Ménétrier disease leading to protein loss and hypoalbuminemia
Histological features:
  • Massive foveolar hyperplasia - the hallmark
  • Glands are elongated with a corkscrew/tortuous appearance
  • Cystic gland dilation is common
  • Marked reduction in oxyntic glands (parietal + chief cells)
  • Inflammation is minimal (not a gastritis - key distinction)
  • Intraepithelial lymphocytosis in some cases

Comparison with Other Hypertrophic Gastropathies

FeatureMénétrier DiseaseZollinger-Ellison Syndrome
LocationBody + fundusFundus
Dominant cellMucous (foveolar)Parietal > mucous
Gastric acidReduced/absentMarkedly increased
Protein lossYesNo
Associated pathologyTGF-α overexpressionGastrinoma (MEN-1)
Dysplasia/cancer riskYesNo
  • Robbins, Cotran & Kumar - Table 17.5

Diagnosis

  1. Endoscopy with deep mucosal biopsy (snare technique preferred for full-thickness sample)
  2. Barium upper GI / CT - characteristic giant folds
  3. Labs: Serum albumin (↓), gastric acid pH (achlorhydria), serum gastrin, CMV and H. pylori serology, CBC
  4. A nondiagnostic endoscopic biopsy may require surgically obtained full-thickness biopsy to exclude malignancy
Differential diagnosis of giant gastric folds:
  • Zollinger-Ellison syndrome
  • Gastric lymphoma / infiltrating carcinoma
  • CMV / syphilis / tuberculosis / histoplasmosis gastritis
  • Sarcoidosis
  • Gastric polyposis (FAP, prolonged PPI use)

Treatment

ApproachDetails
SupportiveIV albumin infusions, parenteral nutritional supplementation
Treat underlying infectionH. pylori eradication, antiviral therapy for CMV
Acid suppressionPPIs, H2 blockers (inconsistent benefit)
Anti-EGFR therapyCetuximab (monoclonal anti-EGFR antibody) - near-complete histologic remission in 4/7 patients in trials - the most targeted therapy
Other agentsOctreotide (somatostatin analogue), anticholinergics, corticosteroids
SurgeryGastrectomy for severe, refractory cases; also performed when malignancy cannot be excluded
In children: disease is usually self-limited; viral clearance (CMV) leads to normalization of epithelial proliferation and restoration of gastric anatomy without surgery.
  • Harrison's Principles of Internal Medicine, 22e
  • Robbins, Cotran & Kumar Pathologic Basis of Disease

Cancer Risk

MD is considered premalignant in adults - retrospective case-control studies show increased risk of gastric adenocarcinoma with decreased 5- and 10-year survival compared to controls. Long-term endoscopic surveillance is warranted.

Cerebriform nuclei with sezary cells

Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Reading File
Loading Image
Finding Sources
Reading File
All the key content is in hand. Here is the complete answer:

Sézary Syndrome - Cerebriform Nuclei

Cerebriform nuclei (also called cerebroid nuclei) - deeply convoluted, brain-like nuclear infolding visible on peripheral blood smear or skin biopsy - are the pathognomonic feature of Sézary cells, defining Sézary Syndrome.

What Are Sézary Cells?

Sézary cells were first described in 1938 by Albert Sézary as large, atypical, mononuclear cells with lobulated, cerebroid nuclei. Their nucleus has marked infolding of the nuclear membrane, creating a convoluted, brain-like (cerebriform) appearance on light microscopy.
They are malignant CD4+ T helper cells that:
  • Home to the skin (via cutaneous lymphocyte antigen / CLA and CCR4)
  • Circulate in the peripheral blood (leukemic phase)
  • Infiltrate lymph nodes

Sézary Syndrome - Definition

"Sézary syndrome is characterized by the triad of diffuse erythroderma, generalized lymphadenopathy, and circulating malignant T cells with cerebriform nuclei - so-called Sézary cells."
  • Fitzpatrick's Dermatology
Sézary Syndrome is the leukemic phase of Cutaneous T-Cell Lymphoma (CTCL) / Mycosis Fungoides (MF), accounting for ~3% of all cutaneous lymphomas.

The Classic Triad

ComponentDetails
1. ErythrodermaGeneralized, intense fiery-red skin involvement; severe pruritus, burning, episodes of chills
2. Generalized lymphadenopathyCervical, axillary, inguinal nodes enlarged
3. Circulating Sézary cellsMalignant T cells with cerebriform nuclei in peripheral blood
Associated findings:
  • Leonine facies (lion-like face from skin thickening)
  • Eyelid edema / ectropion
  • Diffuse alopecia
  • Hyperkeratosis of palms and soles
  • Dystrophic nails
  • Elevated IgE and eosinophilia (Th2 cytokine phenotype)
  • Andrews' Diseases of the Skin

Peripheral Blood Smear - Sézary Cells

Peripheral blood smear of T-cell lymphoproliferative disorders: (A) T-LGL leukemia; (B) Sézary cell with convoluted cerebriform nucleus - note the deeply infolded, brain-like nuclear contour; (C) T-PLL; (D-E) additional variants
Tietz Textbook of Laboratory Medicine, 7th ed. - Panel B shows the classic Sézary cell with its convoluted "cerebriform" nucleus

Relationship to Mycosis Fungoides (MF)

Sézary Syndrome and Mycosis Fungoides are on a spectrum of CTCL:
Mycosis Fungoides (skin-limited CTCL)
     Patch phase → Plaque phase → Tumor phase
                          ↓
              Sézary Syndrome (leukemic phase)
           [erythroderma + blood involvement]
Key distinction:
  • In MF: cutaneous lesions progress through patch → plaque → tumor; skin lesions do proceed to tumefaction
  • In Sézary Syndrome: generalized erythroderma from onset; skin lesions rarely proceed to tumefaction; leukemic cells circulate in blood
Both are tumors of CD4+ helper T cells expressing skin-homing molecules (CLA, CCR4). - Robbins, Cotran & Kumar Pathologic Basis of Disease

Histology of MF/Sézary - Skin Biopsy

FeatureDescription
EpidermotropismNeoplastic T cells infiltrate the epidermis (hallmark)
Pautrier microabscessesClusters of neoplastic T cells within the epidermis - pathognomonic
Cerebriform nucleiMarked nuclear membrane infolding in infiltrating T cells
Band-like dermal infiltrateLymphocytes in upper dermis with admixed histiocytes, eosinophils
Minimal spongiosisUnlike reactive eczema
"T cells with irregular nuclei show single-cell infiltration of the epidermis and often form clusters known as Pautrier abscesses... The nuclei of at least a portion of neoplastic cells typically have a cerebriform appearance." - Henry's Clinical Diagnosis and Management by Laboratory Methods

Immunophenotype

MarkerSézary Cells
CD3+
CD4+ (Th2 phenotype)
CD8-
CD7Lost (in ~2/3 of cases - key aberrant loss)
CD26Lost (majority of cases - useful diagnostic marker)
CD158k/KIR3DL2Aberrantly expressed (normally on NK cells only)
CD4:CD8 ratio in blood is markedly elevated (>10) - a diagnostic criterion.

Diagnostic Criteria (ISCL/EORTC)

Diagnosis of Sézary Syndrome requires:
  1. Erythroderma
  2. Positive T-cell clone in peripheral blood (T-cell receptor gene rearrangement)
  3. At least one B2 criterion, which includes:
    • Absolute Sézary cell count ≥1000 cells/mm³ in peripheral blood
    • CD4:CD8 ratio >10
    • Loss of CD2, CD3, CD4, or CD5 from circulating T cells
    • Lack of CD7 or CD26
Note: Sézary cells alone on cytomorphology are not sufficient - they can be found in other inflammatory erythrodermas (reactive conditions). Clonality must be proven.

Prognosis

DiseaseMedian Survival
MF (patch/plaque stage)~10 years
Sézary Syndrome~3-5 years (5-year OS: 24-43%)
Patients often die from infectious complications (reduced cell-mediated immunity due to malignant replacement of normal T cells). Leukocytosis up to 30,000 cells/mm³ can be present.

Treatment Options

ModalityNotes
Low-dose methotrexate~50% response rate; median survival ~101 months
Extracorporeal photopheresis (ECP)Photophoresis with combination agents; median survival 39-60 months
Total skin electron beam (TSEB) radiationComplete cutaneous responses; also reduces blood burden
PUVA + retinoids + interferon-αCombination skin-directed/systemic
Vorinostat / romidepsinHDAC inhibitors
MogamulizumabAnti-CCR4 antibody; approved for relapsed/refractory MF/SS
AlemtuzumabAnti-CD52
ZanolimumabAnti-CD4
  • Fitzpatrick's Dermatology; Andrews' Diseases of the Skin

Steatorrhoea with duodenal biopsy Fat cells Acanthocytes

Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Finding Sources
Loading Image
Finding Sources
Reading File
All the key information is in hand. Here is the complete answer:

Abetalipoproteinemia (Bassen-Kornzweig Syndrome)

The triad of steatorrhoea + fat-laden enterocytes on duodenal biopsy + acanthocytes on peripheral blood smear is the classic presentation of Abetalipoproteinemia - a rare autosomal recessive disorder of lipoprotein assembly.

Definition

Abetalipoproteinemia (ABL) is a rare autosomal recessive disorder caused by mutation in the gene encoding Microsomal Triglyceride Transfer Protein (MTP), resulting in:
  • Complete inability to assemble and secrete triglyceride-rich lipoproteins (chylomicrons, VLDL, LDL)
  • Intracellular lipid accumulation in enterocytes and hepatocytes
  • Severe fat malabsorption with downstream multi-system consequences
  • Robbins & Kumar Basic Pathology; Yamada's Textbook of Gastroenterology, 7e

Pathogenesis - The MTP Defect

Normal pathway:
Dietary fat → Enterocyte → MTP transfers lipids to ApoB48 → Chylomicron → Lymphatics → Blood

ABL:
MTP mutation → Cannot transfer lipids to ApoB48
             → Chylomicrons CANNOT be formed
             → Lipids TRAPPED inside enterocytes (vacuoles)
             → Fat-laden enterocytes on biopsy
             → Steatorrhoea
             → Fat-soluble vitamin deficiency (A, D, E, K)
ApoB isoforms affected:
IsoformSiteLipoprotein formedIn ABL
ApoB48Enterocytes (edited mRNA)ChylomicronsABSENT
ApoB100Hepatocytes (unedited mRNA)VLDL, LDLABSENT
Both are absent because the defect is in MTP, which is required for both. - Yamada's Textbook of Gastroenterology, 7e

The Three Key Diagnostic Clues Explained

1. Steatorrhoea

Fat cannot be exported from enterocytes (no chylomicrons), so dietary fat is not absorbed. Fat passes through in the stool. Infants present with diarrhea, vomiting, bloating, and failure to thrive from birth. Breast milk (high in fat) is poorly tolerated.

2. Duodenal Biopsy - Fat-Laden Enterocytes

Endoscopic examination of the duodenum and jejunum reveals a "white frosting" appearance coating the mucosa from lipid-filled villi. On histology:
  • Enterocytes packed with lipid-filled cytoplasmic vacuoles (fat droplets trapped inside)
  • Highlighted by Oil Red O stain (especially prominent after a fatty meal)
  • Villous architecture is preserved (distinguishes from coeliac disease)
"In the intestine, endoscopic examination reveals a white frosting appearance coating the duodenum and jejunum due to the lipid content in the mucosa. On histological examination, the enterocytes are filled with numerous lipid-filled cytoplasmic vacuoles." - Yamada's Textbook of Gastroenterology, 7e

3. Acanthocytes (Spur Cells)

Because essential fatty acids cannot be absorbed and transported, the lipid composition of red blood cell membranes is altered. This produces acanthocytes - RBCs with irregular, spiky membrane protrusions - visible on peripheral blood smear.
"Failure to absorb essential fatty acids leads to deficiencies of fat-soluble vitamins as well as lipid membrane defects that can be recognized by the presence of acanthocytes (red cells with spiky membrane protrusions) in peripheral blood smears." - Robbins, Cotran & Kumar Pathologic Basis of Disease

Full Clinical Picture

Presentation timeline:
AgeManifestations
InfancyFailure to thrive, diarrhea, steatorrhoea, vomiting, abdominal distension
ChildhoodFat-soluble vitamin deficiencies become clinically apparent
1st-2nd decadeNeurological + retinal complications if untreated
LateCardiac complications (cardiomyopathy)

Multi-System Complications (from Fat-Soluble Vitamin Deficiency)

DeficiencyConsequence
Vitamin E (most severely depleted - no alternative transport)Spinocerebellar degeneration, peripheral neuropathy, retinitis pigmentosa
Vitamin ANight blindness, retinal degeneration
Vitamin KCoagulopathy (prolonged PT)
Vitamin DMetabolic bone disease
Essential fatty acidsAcanthocytosis, membrane instability

Neurological Syndrome (Bassen-Kornzweig)

Progressive and severe if untreated - develops in the first two decades of life:
  1. Peripheral neuropathy - earliest sign; areflexia, loss of proprioception/vibration (large-fibre), gait ataxia
  2. Spinocerebellar degeneration - cerebellar ataxia of gait, trunk, extremities; dysarthria; titubation
  3. Retinitis pigmentosa - progressive visual field constriction, ring scotomata
  4. Ophthalmoplegia (late)
  5. Skeletal deformity - pes cavus, kyphoscoliosis (secondary to early neuropathy)
  6. Cardiomyopathy - cardiac enlargement, congestive failure (serious late complication)
"Most untreated patients develop retinitis pigmentosa, peripheral neuropathy, and spinocerebellar degeneration during the first two decades of life." - Bradley and Daroff's Neurology in Clinical Practice

Laboratory Findings

TestResult
Serum cholesterolMarkedly low (20-50 mg/dL; normal >150)
Triglycerides (fasting)<10 mg/dL
Post-fat-load triglyceridesNo rise (diagnostic)
Post-fat-load chylomicronsAbsent (diagnostic)
Plasma ApoB48, ApoB100Absent
Vitamin EExtremely low
Vitamins A, D, KLow (but less severely)
Peripheral smearAcanthocytes

Diagnosis Summary

FeatureFinding
GeneticsAutosomal recessive; MTP gene mutation; consanguinity common
EndoscopyWhite frosting of duodenum/jejunum
Duodenal biopsyLipid-vacuolated enterocytes (Oil Red O +); normal villous architecture
Blood smearAcanthocytes (spur cells)
Lipid panelAbsent ApoB, absent chylomicrons, hypocholesterolaemia
NeuroimagingSpinocerebellar atrophy in advanced cases

Treatment

InterventionDetails
Dietary fat restriction<15 g fat/day - minimizes steatorrhoea
Medium-chain triglycerides (MCT)Absorbed directly without chylomicron packaging - provides calories
Vitamin E supplementation100 mg/kg/day (vs. normal 10-30 mg/day) - prevents/arrests neurological complications. If started early (before 16 months), neurological and retinal symptoms do not develop
Vitamins A, K, DStandard supplementation; adequate levels achievable
Key point: Early treatment with high-dose vitamin E can prevent neurological deterioration entirely. Late treatment can halt or partially reverse progression. - Yamada's Textbook of Gastroenterology, 7e

Carneys triad and carneys complex

Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
All the essential content is in hand. Here is the complete side-by-side breakdown:

Carney Triad vs. Carney Complex - A Critical Distinction

These two are completely separate entities - different tumors, different genetics, different inheritance, different eponyms (both named after Dr. J. Aidan Carney, a Mayo Clinic pathologist/endocrinologist).

1. Carney Triad

Definition

First described in the 1970s. A sporadic (non-familial, non-hereditary) syndrome defined by the co-occurrence of three tumor types:
ComponentTumor
1Gastric GIST (Gastrointestinal Stromal Tumor) - often multifocal, with lymph node involvement
2Extra-adrenal Paraganglioma
3Pulmonary Chondroma
All three need not be present simultaneously - the triad may be incomplete and evolve over time.
An expanded description also includes adrenal adenomas and esophageal leiomyomas in some patients. - Sleisenger & Fordtran's GI and Liver Disease

Key Features

FeatureDetail
InheritanceSporadic - NOT familial, NOT inherited
GenderPredominantly young females
AgeYoung patients (often <30 years at presentation)
GeneticsUnknown cause - NOT associated with SDH gene mutations (unlike Carney-Stratakis)
GIST molecular profileKIT/PDGFRA mutation-negative; SDHB-negative by IHC
Imatinib responseGenerally ineffective (KIT/PDGFRA wild-type)
"The Carney triad is a syndrome of unknown cause defined by the co-occurrence of GIST, paraganglioma, and pulmonary chondroma, usually occurring in females." - Robbins, Cotran & Kumar Pathologic Basis of Disease

Carney Triad vs. Carney-Stratakis Dyad (Carney-Stratakis Syndrome)

These are often confused - an important distinction:
Carney TriadCarney-Stratakis Dyad
ComponentsGIST + Paraganglioma + Pulmonary chondromaGIST + Paraganglioma (only 2)
InheritanceSporadicFamilial (autosomal dominant)
GeneticsSDH mutation absentSDH gene mutations (SDHA/B/C/D germline)
SDHB IHCNegativeNegative
Family historyAbsentPresent - family members also affected
"Evaluation has identified that tumors part of the Dyad carry mutations in the SDH family of genes, whereas those associated with the triad do not have such mutations." - Sleisenger & Fordtran's GI and Liver Disease
Clinical implication: Any patient with gastric GIST lacking SDHB expression on IHC requires genetic counseling to distinguish between Carney Triad (sporadic) and Carney-Stratakis Dyad (heritable SDH mutation - family screening needed).

2. Carney Complex

Definition

First described in 1985. An autosomal dominant multiple neoplasia syndrome involving myxomas, skin pigmentation, and endocrine tumors.
Also known historically as:
  • NAME syndrome: Nevi, Atrial myxoma, Myxoid neurofibromas, Ephelides
  • LAMB syndrome: Lentigines, Atrial myxoma, Mucocutaneous myxomas, Blue nevi

The Components

FeatureFrequency
Cardiac myxomas79% - any of 4 chambers; recurrent in 20%; can embolize
Spotty skin pigmentation (lentigines, blue nevi - epithelioid type)65%
Primary Pigmented Nodular Adrenocortical Disease (PPNAD) → Cushing syndrome45%
Cutaneous myxomas (<1 cm papules; ears, eyelids, nipples)45%
Testicular tumors (large-cell calcifying Sertoli cell tumors → sexual precocity/gynecomastia)56% of males
Mammary myxoid fibromas30%
Pituitary somatotrope adenoma → Acromegaly~10%
Psammomatous melanotic schwannomas (sympathetic chain, upper GI)Present
Thyroid tumors, ovarian cystsVariable
"Carney complex is an autosomal dominant disorder characterized by spotty skin pigmentation, myxomas (heart, skin, breast), psammomatous melanotic schwannomas, and endocrine tumors involving the adrenals, Sertoli cells, somatotropes, thyroid, and ovary." - Harrison's Principles of Internal Medicine, 22e

Genetics

TypeGeneChromosome
CNC Type 1 (majority, ~50%)PRKAR1A (Protein Kinase A Regulatory Subunit 1α) - tumour suppressor17q22-24
CNC Type 2Unknown gene2p16
  • PRKAR1A is a tumour suppressor - mutations cause loss of inhibition of PKA (protein kinase A) signalling, leading to uncontrolled cell proliferation

Key Clinical Points for Carney Complex

  1. Cardiac myxomas are life-threatening - can embolize, causing stroke or peripheral ischaemia. Recognition of the syndrome and surgical removal is lifesaving
  2. Cushing syndrome in Carney complex is atypical - patients are often thin (not obese) with normal or only mildly elevated urinary free cortisol; may show periodic/cyclical Cushing's (fluctuating cortisol production)
  3. Pigmentation distribution is characteristic - vermilion border of lips, lacrimal caruncle, conjunctival semilunar fold, sclera (not perioral like Peutz-Jeghers)
  4. Cardiac myxomas are recurrent (20%) and multichambered (unlike sporadic myxomas which are usually solitary left atrial)
  5. Screen first-degree relatives - autosomal dominant inheritance
  • Andrews' Diseases of the Skin; Fitzpatrick's Dermatology

Side-by-Side Comparison Table

FeatureCarney TRIADCarney COMPLEX
Year described1970s1985
NatureTumour syndromeNeoplasia + pigmentation + endocrine syndrome
InheritanceSporadicAutosomal dominant
GeneUnknown (not SDH)PRKAR1A (17q)
Key tumoursGIST + Paraganglioma + Pulmonary chondromaCardiac myxoma + Endocrine tumours + Schwannoma
Gender predominanceYoung femalesEither sex
Life-threatening lesionParagangliomaCardiac myxoma (embolism)
Skin findingsNone specificLentigines, blue nevi (lips, conjunctiva)
Cushing syndromeNoYes (PPNAD) - atypical (thin patient)
SDH mutationAbsentNot relevant
Family screeningNot neededMandatory (AD inheritance)
GIST molecular typeKIT/PDGFRA wild-type, SDHB-negativeNot a feature

Hepatitis c infection with councilman bodies

Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Loading Image
I have all the key content needed. Here is the complete, well-structured answer:

Hepatitis C - Councilman Bodies / Acidophil Bodies

This question hinges on a critical terminological distinction in liver pathology. Understanding it is essential for exams and clinical practice.

The Terminology - Councilman Body vs. Acidophil Body

This is one of the most tested distinctions in hepatic pathology:
TermUsed inMeaning
Councilman bodyYellow fever onlyApoptotic hepatocyte first described by William Thomas Councilman in yellow fever (1890)
Acidophil bodyAll other forms of hepatitis (including HCV)The same morphological entity - apoptotic hepatocyte - but called "acidophil body" by convention in viral hepatitis, drug-induced liver injury, etc.
"Apoptotic hepatocytes were first clearly described in yellow fever by William Thomas Councilman and therefore have been referred to as Councilman bodies; while apoptosis occurs in many forms of liver disease, by convention this eponym is restricted to that disease. In other settings in which apoptotic hepatocytes are seen (e.g., acute and chronic hepatitis), the term acidophil bodies is used, due to their deeply eosinophilic staining characteristics."
  • Robbins, Cotran & Kumar Pathologic Basis of Disease
So the correct terminology in Hepatitis C is acidophil bodies, not Councilman bodies - though they are morphologically identical.

What Is an Acidophil / Councilman Body?

It is a hepatocyte undergoing apoptosis (programmed cell death):
Hepatocyte under immune attack (CD8+ T cells, cytokines)
        ↓
Caspase activation → Programmed cell death
        ↓
Hepatocyte SHRINKS (opposite of necrosis which swells)
        ↓
Nuclear chromatin condensation (pyknosis)
        ↓
Nuclear fragmentation (karyorrhexis)
        ↓
Cell fragments into small, densely eosinophilic globules
        ↓
ACIDOPHIL BODY (deeply pink/eosinophilic, anucleate or with pyknotic nucleus)
These round, shrunken, deeply eosinophilic (acidophilic) apoptotic bodies are extruded into the sinusoids or remain in the hepatic parenchyma and are rapidly phagocytosed.

Hepatitis C Liver Biopsy - Histological Features

The liver biopsy in chronic HCV infection has characteristic histological findings. Acidophil bodies are one component of the overall picture:
Hepatocyte apoptosis in chronic hepatitis C biopsy. Single arrows show scattered apoptotic hepatocytes ("acidophil bodies") - shrunken, deeply eosinophilic. Double arrows show patchy inflammatory infiltrate.
Fig. 14.3 - Robbins & Kumar Basic Pathology: Biopsy from a patient with chronic hepatitis C showing acidophil bodies (single arrows) and patchy inflammatory infiltrate (double arrows)

Complete Histological Picture of Chronic HCV

FeatureDescription
Acidophil bodiesScattered apoptotic hepatocytes - shrunken, deeply eosinophilic, anucleate; hallmark of ongoing hepatocyte death
Portal tract lymphoid aggregatesDense lymphoid follicle-like aggregates in portal tracts - characteristic of HCV (less common in HBV)
Bile duct damageLymphocytic infiltration and damage of interlobular bile ducts ("biliary injury") - HCV-specific
SteatosisMacrovesicular fat - particularly prominent in HCV genotype 3 (direct viral steatosis); also in other genotypes (metabolic steatosis)
Interface hepatitisLymphocytic spillover from portal tracts into surrounding periportal hepatocytes ("piecemeal necrosis")
Lobular inflammationScattered intralobular lymphocytes and Kupffer cell activation
Sinusoidal lymphocytosisSingle-file lymphocytes in sinusoids ("string of beads")
Perisinusoidal/pericellular fibrosisWith progressive disease
CirrhosisEnd-stage - nodular regeneration with bridging fibrosis
Note - what is NOT seen in HCV (unlike HBV):
  • No "ground glass" hepatocytes - Ground glass cells (HBsAg-laden smooth ER) are specific to HBV, not HCV

Mechanism of Hepatocyte Death in HCV

The immune response is the primary driver:
HCV RNA replication in hepatocytes
        ↓
Viral antigens presented on MHC Class I
        ↓
CD8+ cytotoxic T lymphocytes recognize and attack infected hepatocytes
        ↓
Perforin/granzyme pathway → Caspase activation → APOPTOSIS
Fas/FasL pathway → Caspase activation → APOPTOSIS
        ↓
Acidophil bodies form
        ↓
Hepatic stellate cell activation by cytokines (TGF-β, TNF-α)
        ↓
Perisinusoidal myofibroblasts → Collagen deposition → FIBROSIS → CIRRHOSIS
"Adaptive immune cells play a critical role in viral hepatitis, with CD4+ and CD8+ T cells being particularly important in the eradication of virus-infected hepatocytes and in causing liver injury in chronic disease." - Robbins & Kumar Basic Pathology

Summary - Key Points for Exams

PointFact
Councilman bodies = Yellow fever onlyFirst described by W.T. Councilman, 1890
Same structure in HCV = Acidophil bodiesNamed for deep eosinophilic staining
MechanismHepatocyte apoptosis (NOT necrosis)
MorphologyShrunken, deeply eosinophilic, pyknotic/anucleate globules
HCV-specific histological featuresPortal lymphoid aggregates + bile duct damage + steatosis + acidophil bodies
Ground glass cellsHBV only (NOT HCV)
Fibrosis driverHepatic stellate cell → myofibroblast → collagen
This is a shared conversation. Sign in to Orris to start your own chat.